HCCI's work on insulin pricing was cited in a Boston Globe article. From the article: "Following similar efforts in Colorado and Minnesota, the Senate bill also targets the costs of insulin, a commonly used drug that has become increasingly unaffordable for many patients. On average, the price of all types of insulin roughly doubled between 2012 and 2016, according to the Washington-ba...
Annual Reports
HCCI’s Health Care Cost and Utilization Reports
Yearly reviews of spending, price and utilization trends for commercially-insured Americans. Learn more about our methodology, definitions, and other resources.